87 related articles for article (PubMed ID: 14714424)
1. Gene targeting in vivo with pegylated immunoliposomes.
Pardridge WM
Methods Enzymol; 2003; 373():507-28. PubMed ID: 14714424
[No Abstract] [Full Text] [Related]
2. A modified protocol for efficient DNA encapsulation into pegylated immunoliposomes (PILs).
Skjørringe T; Gjetting T; Jensen TG
J Control Release; 2009 Oct; 139(2):140-5. PubMed ID: 19545595
[TBL] [Abstract][Full Text] [Related]
3. Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes.
Shi N; Boado RJ; Pardridge WM
Pharm Res; 2001 Aug; 18(8):1091-5. PubMed ID: 11587478
[TBL] [Abstract][Full Text] [Related]
4. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer.
Zhang Y; Zhang YF; Bryant J; Charles A; Boado RJ; Pardridge WM
Clin Cancer Res; 2004 Jun; 10(11):3667-77. PubMed ID: 15173073
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive gene targeting to the fetal brain after intravenous administration and transplacental transfer of plasmid DNA using PEGylated immunoliposomes.
Cornford EM; Hyman S; Cornford ME; Chytrova G; Rhee J; Suzuki T; Yamagata T; Yamakawa K; Penichet ML; Pardridge WM
J Drug Target; 2016; 24(1):58-67. PubMed ID: 26133964
[TBL] [Abstract][Full Text] [Related]
6. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.
Kirpotin DB; Drummond DC; Shao Y; Shalaby MR; Hong K; Nielsen UB; Marks JD; Benz CC; Park JW
Cancer Res; 2006 Jul; 66(13):6732-40. PubMed ID: 16818648
[TBL] [Abstract][Full Text] [Related]
7. Decline in exogenous gene expression in primate brain following intravenous administration is due to plasmid degradation.
Chu C; Zhang Y; Boado RJ; Pardridge WM
Pharm Res; 2006 Jul; 23(7):1586-90. PubMed ID: 16779704
[TBL] [Abstract][Full Text] [Related]
8. Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes.
Judge A; McClintock K; Phelps JR; Maclachlan I
Mol Ther; 2006 Feb; 13(2):328-37. PubMed ID: 16275098
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect.
Zhang Y; Rong Qi X; Gao Y; Wei L; Maitani Y; Nagai T
J Control Release; 2007 Feb; 117(2):281-90. PubMed ID: 17196291
[TBL] [Abstract][Full Text] [Related]
10. Post-pegylated lipoplexes are promising vehicles for gene delivery in RPE cells.
Peeters L; Sanders NN; Jones A; Demeester J; De Smedt SC
J Control Release; 2007 Aug; 121(3):208-17. PubMed ID: 17630013
[TBL] [Abstract][Full Text] [Related]
11. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
Désormeaux A; Bergeron MG
Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
[TBL] [Abstract][Full Text] [Related]
12. Anionic pH-sensitive pegylated lipoplexes to deliver DNA to tumors.
Mignet N; Richard C; Seguin J; Largeau C; Bessodes M; Scherman D
Int J Pharm; 2008 Sep; 361(1-2):194-201. PubMed ID: 18586422
[TBL] [Abstract][Full Text] [Related]
13. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro targeting of sterically stabilized liposomes modified with chimeric TNT-3 monoclonal antibody.
Pan H; Niu GQ; Pan J; Lu WY
Yao Xue Xue Bao; 2006 Jun; 41(6):506-12. PubMed ID: 16927823
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody-based quantitation of poly(ethylene glycol)-derivatized proteins, liposomes, and nanoparticles.
Cheng TL; Cheng CM; Chen BM; Tsao DA; Chuang KH; Hsiao SW; Lin YH; Roffler SR
Bioconjug Chem; 2005; 16(5):1225-31. PubMed ID: 16173802
[TBL] [Abstract][Full Text] [Related]
16. Cationic liposome-mediated gene delivery in vivo.
Liu Y; Fong S; Debs RJ
Methods Enzymol; 2003; 373():536-50. PubMed ID: 14714426
[No Abstract] [Full Text] [Related]
17. Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries.
Hülsermann U; Hoffmann MM; Massing U; Fricker G
J Drug Target; 2009 Sep; 17(8):610-8. PubMed ID: 19694613
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of liposomal nanocontainers to the peritumoral zone of glioma by means of monoclonal antibodies against GFAP and the extracellular loop of Cx43.
Chekhonin VP; Baklaushev VP; Yusubalieva GM; Belorusova AE; Gulyaev MV; Tsitrin EB; Grinenko NF; Gurina OI; Pirogov YA
Nanomedicine; 2012 Jan; 8(1):63-70. PubMed ID: 21703991
[TBL] [Abstract][Full Text] [Related]
19. Targeted gene therapy of LS174 T human colon carcinoma by anti-TAG-72 immunoliposomes.
Kim KS; Lee YK; Kim JS; Koo KH; Hong HJ; Park YS
Cancer Gene Ther; 2008 May; 15(5):331-40. PubMed ID: 18309354
[TBL] [Abstract][Full Text] [Related]
20. Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats.
Takahama H; Minamino T; Asanuma H; Fujita M; Asai T; Wakeno M; Sasaki H; Kikuchi H; Hashimoto K; Oku N; Asakura M; Kim J; Takashima S; Komamura K; Sugimachi M; Mochizuki N; Kitakaze M
J Am Coll Cardiol; 2009 Feb; 53(8):709-17. PubMed ID: 19232905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
